Our videos, posts, topics, and insights address clinical matters and issues that are directly or indirectly related to our clinical scope of practice
The immunotoxicity effect of monocytes and lymphocytes against target cells of mammary carcinoma (K562 and MDA-MB-231) was tested in vitro after 10 days of oral bromelain administration in breast cancer patients (daily up to a dose of 7800 mg) as above mentioned (paragraph 4.4) (Eckert et al., 1999)
[DOI] [PubMed] [Google Scholar] 99.Knop F.K., Aroda V.R., do Vale R.D., Holst-Hansen T., Laursen P.N., Rosenstock J., Rubino D.M., Garvey W.T., OASIS 1 Investigators Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): A randomised, double-blind, placebo-controlled, phase 3 trial
This is also important to consider when taking quick-access supplements like our [GLP-1 Daily Support] or [Weight Loss Boost]